HopeStage
Back to all studies
CompletedNCT00148083

Long-acting risperidone with social skills training for schizophrenia

About this titleRead the official source — NCT00148083
Medication studyAges 18–55United States
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.

Listed locations
Chicago and 1 more locationSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2005
Recruitment status
Completed
Enrollment listed in the registry
5
Sponsor
University of Illinois Chicago
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT00148083
Official title
Show the full official title

Efficacy of Risperidone Consta for Improving Ability to Benefit From Skills Training in Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Chicago · White Plains

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Illinois Chicago, a university.

Did this study involve medication?

Yes. The study involved medication, including Risperdal Consta (drug).

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies